Studies | EBMT

Top

Study type

Disease

Group

Type of treatment

Text

Trends in Hematopoietic Stem Cell Transplantation for Patients with Diffuse Large B-Cell Lymphoma. A Retrospective Analysis of the Lymphoma WP of the EBMT

Retrospective Studies

Non-Hodgkin’s Lymphoma (NHL)

Lymphoma Working Party (LWP)

Type of treatment

Principal investigator

Norbert Schmitz, Anna Sureda

Efficacy and toxicity of CAR T cell therapy in patients with primary and secondary central nervous system lymphoma

Retrospective Studies

Non-Hodgkin’s Lymphoma (NHL)

GoCART Coalition

Lymphoma Working Party (LWP)

Type of treatment

Principal investigator

Anna Ossami Saidy

Post-transplantation cyclophosphamide-based after HLA-matched versus haploidentical donor transplants in patients with Hodgkin lymphoma: a comparative study of the LWP EBMT

Retrospective Studies

Non-Hodgkin’s Lymphoma (NHL)

Lymphoma Working Party (LWP)

Type of treatment

Allogeneic - Haploidentical

Principal investigator

Dr. Juan Montoro

Frequency and Impact of Pre-Transplant Somatic Co-Occurring Mutations on Clinical Outcomes of Acute Myeloid Leukemia Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation: On Behalf of the EBMT Acute Leukemia Working Party

Retrospective Studies

Acute Myeloid Leukaemia (AML)

Acute Leukemia Working Party (ALWP)

Type of treatment

Principal investigator

Long term outcomes and relative mortality in survivors of allogeneic hematopoietic cell transplantation in acute myeloid leukemia: an analysis from the ALWP of the EBMT

Retrospective Studies

Acute Myeloid Leukaemia (AML)

Acute Leukemia Working Party (ALWP)

Type of treatment

Principal investigator

Outcome of haploidentical transplant in chronic granulomatous disease

Retrospective Studies

Inherited disorders

Inborn Errors Working Party (IEWP)

Type of treatment

Allogeneic - Haploidentical

Principal investigator

Benedicte Neven

Prospective study on the incidence and outcome of HHV-6 encephalitis in patients who undergo allogeneic haploidentical HSCT

Non-interventional Prospective Studies

Complications: infectious

Infectious Diseases Working Party (IDWP)

Type of treatment

Allogeneic - Haploidentical

Principal investigator

Katia Perruccio

Allo-HCT in CLL after multiple pathway inhibitors.

Retrospective Studies

Chronic Lymphocytic Leukaemia (CLL)

Chronic Malignancies Working Party (CMWP)

Type of treatment

Principal investigator

Michel van Gelder/Olivier Tournilhac

Outcomes following the use of PTCy in URD allo-HCT for CML

Retrospective Studies

Chronic Myeloid Leukaemia (CML)

Chronic Malignancies Working Party (CMWP)

Type of treatment

Allogeneic - Unrelated

Principal investigator

Autologous Peripheral Blood Stem Cell Mobilisation Techniques, Stem Cell Yields and Practice Variation-By-Country in Patients with Myeloma Undergoing First Autologous Stem Cell Transplants in EBMT Centres.

Retrospective Studies

Multiple Myeloma (MM) or other Plasma Cell Disorder (PCD)

Chronic Malignancies Working Party (CMWP)

Type of treatment

Principal investigator

Outcomes of Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) in Patients with CALR-Mutated Myelofibrosis compared to those patients with a JAK2-mutation.

Retrospective Studies

Myeloproliferative Neoplasm (MPN)

Chronic Malignancies Working Party (CMWP)

Type of treatment

Principal investigator

Juan Carlos Hernández-Boluda

GvHD Prophylaxis Incorporating Methotrexate in Allo-HCT for Chronic Myeloid Malignancies and sAML: A Retrospective Analysis from the CMWP of the EBMT.

Retrospective Studies

Chronic Myeloid Leukaemia (CML)

Myelodysplastic (MDS) or MDS/MPN

Myeloproliferative Neoplasm (MPN)

Chronic Malignancies Working Party (CMWP)

Type of treatment

Principal investigator